J Hematol Oncol. 2008 Oct 29;1:20.

First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting.

Source

Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Canada. lim.che.kang@sgh.com.sg

Abstract

This review summarizes phase I trial results of 11 drugs presented at the American Society of Clinical Oncology meeting held in Chicago IL from May 30 to June 3rd 2008: BMS-663513, CT-322, CVX-045, GDC-0449, GRN163L, LY2181308, PF-00562271, RAV12, RTA 402, XL765, and the survivin vaccine.

PMID:: 18959794; [PubMed - indexed for MEDLINE]
PMCID: PMC2647552

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

Congresses

MeSH Terms

Substances

Antineoplastic Agents

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004. [Anticancer Drugs. 2005]
New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.
Caponigro F, Basile M, de Rosa V, Normanno N. Anticancer Drugs. 2005 Feb; 16(2):211-21.
American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA. [IDrugs. 2003]
American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA.
Erlich R, Durrance A. IDrugs. 2003 Jul; 6(7):628-30.
American Society of Clinical Oncology--46th annual meeting. [IDrugs. 2010]
American Society of Clinical Oncology--46th annual meeting.
Al-Shamahi A, Murch L, Kirkham K. IDrugs. 2010 Aug; 13(8):506-9.
Review Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology. [J Clin Oncol. 1997]
Review Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology.
. J Clin Oncol. 1997 Feb; 15(2):853-9.
Review Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010. [JOP. 2010]
Review Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Dimou AT, Syrigos KN, Saif MW. JOP. 2010 Jul 5; 11(4):324-7. Epub 2010 Jul 5.

See reviews... See all...

Cited by 15 PubMed Central articles

Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer. [Mol Cancer. 2011]
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.
Serrano D, Bleau AM, Fernandez-Garcia I, Fernandez-Marcelo T, Iniesta P, Ortiz-de-Solorzano C, Calvo A. Mol Cancer. 2011 Aug 9; 10:96. Epub 2011 Aug 9.
Review Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors. [Curr Med Chem. 2011]
Review Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors.
Shuttleworth SJ, Silva FA, Cecil AR, Tomassi CD, Hill TJ, Raynaud FI, Clarke PA, Workman P. Curr Med Chem. 2011; 18(18):2686-714.
Review Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. [Oncotarget. 2011]
Review Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.
Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone P, et al. Oncotarget. 2011 Mar; 2(3):135-64.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

First-in-class, first-in-human phase I results of targeted agents: highlights of...
First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting.
J Hematol Oncol. 2008 Oct 29 ;1:20.

PubMed
Effect of arginase II on L-arginine depletion and cell growth in murine cell lin...
Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.
J Hematol Oncol. 2008 Sep 25 ;1:14.

PubMed
Rosai dorfman disease of the orbit.
Rosai dorfman disease of the orbit.
J Hematol Oncol. 2008 Jun 28 ;1:7.

PubMed
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrenc...
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.
J Hematol Oncol. 2010 Aug 19 ;3:27.

PubMed
Left sided inferior vena cava duplication and venous thromboembolism: case repor...
Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature.
J Hematol Oncol. 2008 Dec 2 ;1:24.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: